Meeting
2023 ASCO Annual Meeting
HPV integration as a prognostic biomarker for metastatic anal cancer: A next-generation sequencing ctDNA-based approach.
Authors
Benny Johnson
Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Benny Johnson , Helene Pelicano , Ryan W Huey , Robert A. Wolff , Ignacio Ivan Wistuba , Dzifa Yawa Duose , Saradhi Mallampati , Rajyalakshmi Luthra , Van K. Morris II
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Colorectal and Anal
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Anal Cancer
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 3525)
DOI
10.1200/JCO.2023.41.16_suppl.3525
Abstract #
3525
Poster Bd #
225
Abstract Disclosures
Similar Posters
Poster
2014 Gastrointestinal Cancers Symposium
Association of human papillomavirus with unique clinicopathologic features in patients with metastatic squamous cell carcinoma of the anal canal.
First Author: Van Karlyle Morris II
Poster
2024 ASCO Annual Meeting
Matched tissue and circulating tumor DNA (ctDNA) analysis in renal cell carcinoma (RCC): Results from a multimodal real-world database.
First Author: Rana R. McKay
Poster
2024 ASCO Genitourinary Cancers Symposium
Characterizing longitudinal molecular changes in ctDNA in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).
First Author: Eli Tran
Poster
2024 ASCO Genitourinary Cancers Symposium
High expression of sialylated cancer-derived IgG and survival in metastatic clear cell renal cell carcinoma.
First Author: Jie Wu